文献速递血管炎

线粒体DNA:ANCA相关性血管炎活动性炎症的新型指标

Mitochondrial DNA: a novel indicator of active inflammation in ANCA-associated vasculitides.
PubMed 文献 · Rheumatology (Oxford) · 2023-01-01

该前瞻性研究纳入101例ANCA相关性血管炎(AAV)患者和92名健康对照,采用PCR定量血浆游离线粒体DNA(mtDNA)和核DNA(nDNA)。AAV患者mtDNA中位数较健康对照高13倍,且活动期患者较缓解期高4倍,mtDNA与BVAS相关并与AAV活动独立关联,而nDNA无差异。

要点

  • AAV患者血浆mtDNA中位数较健康对照高13倍,nDNA浓度无差异。
  • 活动期AAV(BVAS>0)患者mtDNA中位数较缓解期患者高4倍(P=0.03)。
  • 27例随访患者中mtDNA变化与BVAS变化相关(r=0.56,P=0.002),而CRP或ANCA滴度无此相关。

核心结论

  • mtDNA而非nDNA在AAV患者血浆中升高,可能参与系统性炎症。
  • mtDNA在AAV活动性的实验室监测中可能优于现有生物标志物。

研究设计与样本

  • 前瞻性研究,纳入连续GPA和MPA患者及健康对照,从无血小板血浆中分离DNA,用PCR定量mtDNA和nDNA拷贝数,并收集包括BVAS在内的临床数据。

主要发现

  • 共纳入92名健康对照(中位年龄51岁,女性58.7%)和101例AAV患者(80例GPA,21例MPA,中位年龄64岁,女性50.5%,BVAS范围0-30)。
  • AAV患者mtDNA中位数较健康对照高13倍;nDNA浓度无差异。
  • 活动期AAV(BVAS>0)患者mtDNA中位数较缓解期患者高4倍(P=0.03)。
  • mtDNA与BVAS相关(r=0.30,P=0.002),而nDNA不相关;多变量分析显示mtDNA与AAV活动性相关。
  • ROC曲线分析显示mtDNA定量区分活动期AAV(BVAS>0)与健康对照的敏感性为96.1%、特异性为98.9%(曲线下面积0.99)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: ANCA-associated vasculitis (AAV) includes granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). ANCA triggers neutrophil extracellular trap formation, which releases either mitochondrial (mt) DNA or nuclear DNA (n) DNA, contributing to inflammation. Our aim was to prospectively examine the extent and nature of circulating DNA in AAV and the clinical utility of DNA quantification. METHODS: DNA was isolated from platelet-free plasma of consecutive GPA and MPA patients and healthy controls (HCs). mtDNA and nDNA copy numbers were quantified by PCR. Clinical data, including the BVAS, were collected. RESULTS: Ninety-two HCs (median age 51 years, 58.7% female) and 101 AAV patients (80 GPA, 21 MPA, median age 64 years, 50.5% female, BVAS range: 0-30) were included. Median mtDNA copies were 13-fold higher in patients with AAV than in HCs; nDNA concentrations did not differ. Patients with active AAV (BVAS > 0) had 4-fold higher median mtDNA copies than patients in remission (P = 0.03). mtDNA, unlike nDNA, correlated with BVAS (r = 0.30, P = 0.002) and was associated with AAV activity at multivariable analysis. Receiver operating characteristic curve analysis indicated that mtDNA quantification differentiates patients with active AAV (BVAS > 0) from HCs with 96.1% sensitivity and 98.9% specificity (area under the curve 0.99). In 27 AAV patients with follow-up, mtDNA changes but not CRP or ANCA-titres correlated with BVAS changes (r = 0.56, P = 0.002). CONCLUSIONS: mtDNA, unlike nDNA, is elevated in the plasma of AAV patients and may contribute to systemic inflammation. mtDNA could be superior to established biomarkers in the laboratory monitoring of AAV activity.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Giaglis S, Daoudlarian D, Thiel J, et al. Mitochondrial DNA: a novel indicator of active inflammation in ANCA-associated vasculitides. Rheumatology (Oxford). 2023. PMID: 36645235. doi:10.1093/rheumatology/kead015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。